MML Investors Services’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,558
Closed -$218K 2884
2025
Q1
$218K Sell
5,558
-44
-0.8% -$1.98K ﹤0.01% 2500
2024
Q4
$260K Sell
5,602
-522
-9% -$23.6K ﹤0.01% 2351
2024
Q3
$277K Sell
6,124
-6,596
-52% -$314K ﹤0.01% 2234
2024
Q2
$627K Buy
12,720
+433
+4% +$17.7K ﹤0.01% 1648
2024
Q1
$422K Sell
12,287
-2,793
-19% -$101K ﹤0.01% 1895
2023
Q4
$556K Buy
15,080
+2,438
+19% +$56.4K ﹤0.01% 1687
2023
Q3
$256K Sell
12,642
-1,214
-9% -$26.7K ﹤0.01% 2027
2023
Q2
$283K Buy
+13,856
New +$208K ﹤0.01% 1968

Other funds holding TWST

MML Investors Services's TWST Position: Q2 2025 in Review

MML Investors Services sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 5,558 shares — an estimated $218K sold.

MML Investors Services first reported a position in TWST in Q2 2023 and held it in 8 quarters. The position peaked at $627K in Q2 2024. 243 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

  • MML Investors Services reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
  • MML Investors Services sold 5,558 Twist Bioscience shares in Q2 2025, an estimated $218K.
  • MML Investors Services first reported a position in Twist Bioscience in Q2 2023 and held it in 8 quarters.
  • MML Investors Services's Twist Bioscience position peaked at $627K in Q2 2024.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on MML Investors Services's 13F filing for Q2 2025, filed 14 Aug 2025.